choroid) were examined during the period 1987-1995. The majority of patients were treated by enucleation (removal of the eye), although six patients underwent local resection of the primary tumour. The cohort consisted of 29 males and 13 females, ranging in age from 43 to 90 years (median 66 years). Estimation of tumour size was conducted preoperatively by B scan ultrasonography (Cooper Vision), and the longest tumour diameter in contact with the sclera was determined (Ltd). All melanomas were categorized histopathologically according to the AFIP system of classification for uveal melanoma (Spencer, 1986) . The clinicopathological details of the previously unreported patients are presented in Table 1 .
Cytogenetic analysis
Uveal melanoma biopsies were processed immediately upon resection as previously reported (Sisley et al, 1990 (Sisley et al, , 1997 . Tumour cultures were continually assessed, and when sufficient growth had been procured, cells were harvested and chromosome preparations made and banded (Sisley et al, 1990) , with abnormalities recorded in accordance with international guidelines (ISCN, 1991) .
Statistical analysis
Statistical association was assessed by constructing 2×2 contingency tables of the variables. Statistical significance was evaluated using Pearson χ 2 and Fishers' Exact test with a P-value of < 0.05 taken to indicate significance.
RESULTS
Cytogenetic analysis and the clinical and histopathological details of 18 patients has been reported previously. Cases Som 10, 11, 17, 22, 30 and 35 were presented in Sisley et al (1990) , cases Som 36, 37, 47, 52, 53, 57, 59, 60, 61, 62 and 63, were detailed in Sisley et al (1992) and cases Som 95 and 140 reported in Tappin et al (1996) . The significance of chromosome 3 and 8 abnormalities in the series of 42 patients has been considered separately (Sisley et al, 1997) . Cytogenetic analysis from the uveal melanomas is detailed in Table 2 and the clinicopathological details are presented in Table 1 .
The results of cytogenetic analysis for all 42 cases was examined. The incidence for involvement of individual chromosomes in numerical and structural changes was ascertained as a percentage of tumours possessing such abnormalities (results not shown). In a given tumour, if aneuploidy of both homologues was present, or if both experienced structural rearrangements, the occurrence was only recorded once. From the study the commonest chromosome abnormalities were confirmed to be loss of chromosome 3 (21 tumours, 50% of melanomas) and the Y chromosome (16 tumours, 38% of melanomas), and structural alterations of chromosomes 1, 6 and 8 (13, 16 and 21 tumours representing 30%, 38% and 50% of melanomas respectively). The distribution of breakpoints for structural alterations in the series was determined (Figure 1) , and although most chromosomes experienced some rearrangement, the occurrence of breakpoints was not random. Chromosome 8 was the most heavily implicated in structural rearrangements, with breakpoints concentrated at the centromeric region, whilst both arms of chromosome 6 were equally represented. Breakpoints on chromosome 1 were predominantly at the centromeric region, and, in common with other breakpoints on chromosome 1p, produced an effectual deletion of the short arm, often as a result of unbalanced translocations (Figure 2 ). Also of interest was the apparent hotspot at chromosome 11q23 (Figure 1 ).
To associate chromosome abnormalities with phenotypic features, the incidence of numerical and structural alterations was determined in relation to tumour location, size and cell type (Figures 3 and 4) . The significance of the specific changes of chromosomes 3 (loss) and 8 has been previously recounted (Sisley et al, 1997) , and will not be considered in this report. Structural alterations of chromosome 6 (p and q) were found in both ciliary body (8/24 tumours) and choroid melanomas (8/18 tumours) (P = 0.46). Trisomy of chromosome 21 occurred more frequently in ciliary body melanomas (6/24) although this did not achieve statistical significance (P = 0.23). Similarly, chromosome 1 p deletions were found predominantly in ciliary body melanomas (11/24); this was statistically significant (P = 0.016). Abnormalities of chromosome 11 occurred more frequently in choroidal tumours, again this failed to achieve statistical significance (P = 0.10). From comparison of the cytogenetic changes with increasing tumour size, it was observed that an increase in tumour size, whether in the diameter, thickness or volume, was associated with an increase in the number of chromosomes partaking in numerical changes ( Figure 4A ). Tumours greater than 15 mm in diameter possessed approximately three times the numbers of total numerical abnormalities compared with those of less than 15 mm diameter, although a corresponding increase for structural alterations was not observed ( Figure 4B ). When individual homologues were considered, abnormalities of chromosomes 1, 3, 6, 8, Figure 1 Idiogram showing distribution of breakpoints for structural alterations in the series. q denotes a tumour with a breakpoint in this region, q denotes five tumours with breakpoints s denotes a tumour with a possible breakpoint in this region.
9, 10, 17 and Y were found to be more common in the larger tumours ( Figure 4 ), although involvement was not significant for any chromosome (P = 0.31, P = 0.18, P = 0.50, P = 0.37, P = 0.053, P = 0.07, P = 0.15 and P = 0.51 respectively). No specific trends for chromosome abnormalities could be related to cell type (data not shown).
DISCUSSION
The association of chromosomes 3, 6 and 8 changes with posterior uveal melanoma has been clearly documented (Prescher et al, 1990 (Prescher et al, , 1995 Sisley et al, 1990 Sisley et al, , 1992 Dahlenfors et al, 1993; Horsman and White, 1993; Wiltshire et al, 1993; Singh et al, 1994) . Equally well recognized is the relationship between chromosome 6 and cutaneous melanoma (Ray et al, 1996) , and the observation that similar alterations of chromosome 6 occur in uveal melanoma (Prescher et al, 1990 (Prescher et al, , 1995 Sisley et al, 1990; Horsman and White, 1993; Wiltshire et al, 1993; Singh et al, 1994) . It is unclear as to which chromosome changes may be considered to be related to a general pathology of cell type, such as neural crest derivation, or even melanoma associated changes, and what changes, if any, depict differences in those melanomas arising in sites other than the skin. Indeed recent evidence suggests that amongst uveal melanomas (ciliary body, choroid and iris) those melanomas arising in the iris have cytogenetic abnormalities different to those of the posterior uvea (White et al, 1995; Sisley et al, 1998) , and as iris melanomas are by comparison relatively benign (Sunba et al, 1980) , it is possible that these differences may account for variations in aggressive behaviour. It is of interest that as the tumour enlarges there is a demonstrable increase in the numerical changes, whilst structural alterations show no such pattern. Greater aneuploidy may either be representative of specific essential changes associated with tumour progression, or, with the exception of chromosome 3 loss, indicate unrelated 'background noise' illustrative of the presumably advanced nature of these tumours (Johansson et al, 1996) . Cytogenetic abnormalities can be segregated into balanced and unbalanced aberrations, according to their ultimate effect on the genetic constitution (Johansson et al, 1996) . Under this model balanced structural abnormalities, such as translocations or inversions, result in gene rearrangements and can be considered as primary, whereas numerical changes, trisomies and monosomies, produce gross genetic imbalances and would be considered secondary (Johansson et al, 1996) . In uveal melanoma most alterations yield unbalanced rearrangements and would therefore fall into the category of secondary, possibly unrelated changes (Johansson et al, 1996) . It is also important to consider the potential implications of the mechanics behind these abnormalities. Numerical changes may simply arise as the by-product of poorly regulated cell division, comparable to the increased genetic instability associated with p53 or BUB1 mutant cells (Agapova et al, 1996; Cahill et al, 1998) , and therefore occur more frequently in the larger uveal melanomas as a result of other, perhaps undetected, genetic abnormalities. Structural alterations require DNA breakage and reunion, and in uveal melanoma they occur without particular regard to increasing tumour size, with the possible exceptions of rearrangements of chromosomes 9 and 10 which are found in cutaneous and some uveal melanomas (Magauran et al, 1994; Healy et al, 1995; Ohta et al, 1996) . It is possible that structural abnormalities could conceivably represent a more specific mechanism than for most numerical changes; regardless of whether they transpire to be primary or secondary aberrations. In uveal melanoma certain alterations, particularly those of chromosomes 3 and 8, are known to be more common in tumours arising from select locations (Sisley et al, 1990 (Sisley et al, , 1992 Prescher et al, 1992 Prescher et al, , 1996 Dahlenfors et al, 1993; Horsman and White, 1993; Singh et al, 1994) , and the results of this study, in combination with previous cytogenetic analysis, would suggest that this classification can be extended to include other alterations. In ciliary body melanomas, or those of a mixed location, structural abnormalities of chromosomes 1 and 8, and aneuploidy of chromosomes 3 and 21, are more frequently observed (Sisley et al, 1990 (Sisley et al, , 1992 Dahlenfors et al, 1993; Horsman and White, 1993; Wiltshire et al, 1993; Singh et al, 1994; Prescher et al, 1995) . In choroid melanomas, or again those of a mixed location, rearrangements of chromosomes 6 and 11 are more likely (Sisley et al, 1990 (Sisley et al, , 1992 Dahlenfors et al, 1993; Horsman and White, 1993; Singh et al, 1994; Prescher et al, 1995) . An interesting paradox can be seen when observing mixed ciliary body/choroid melanomas, as they appear to combine chromosome aberrations from both localities. In these mixed melanomas abnormalities of chromosomes 1, 3, 6, 8, 11 and 21 are all found, although at the other extremes, changes of chromosomes 1, 3, 8 and 21 are infrequent amongst those melanomas entirely derived from the choroid, whilst equally rare are rearrangements of chromosomes 6 and 11 in purely ciliary body-derived melanomas. It is unclear why these mixed melanomas possess abnormalities of both locations, but it is possible that environmental factors may play a role. This association with tumour location may explain why chromosome alterations are predictive of survival. Ciliary body melanomas have a worse prognosis (McLean et al, 1977) , and recent evidence (15) suggests that abnormalities of chromosomes 3 and 8 identify a poor outcome, whilst those of chromosome 6, more common in choroid melanomas, are a good prognostic indicator (Prescher et al, 1996; Sisley et al, 1997; White et al, 1998) . At least in terms of their cytogenetic alterations it would appear that these two melanomas have different genetic backgrounds, leading to speculation that in some way the locality itself dictates the genetic changes required for the tumour to progress, a suggestion perhaps compounded by the observation that the relatively benign iris melanomas have different changes (White et al, 1995; Sisley et al, 1998) . Through comparison of tumour enlargement with chromosome changes, it is apparent that certain aberrations become more frequent as the tumour progresses, including those of chromosomes 1, 3, 6, 8, 11 and Y, already identified as non-randomly involved. In addition trisomy of chromosome 21 and structural alterations of chromosomes 9, 10 and 17 also occur (Figure 4) . Deletions of chromosomes 9, 10 and 17 are found in cutaneous melanomas (Healy et al, 1995) , and uveal melanomas have also been shown to have loss of regions on chromosome 9 (Magauran et al, 1994; Ohta et al, 1996) . As changes of chromosomes 1, 3, 8 and 21 are more common to melanomas with a ciliary body component (Figure 3) , and because of their progressive acquisition, the sequence of cytogenetic alterations for ciliary body melanomas could be proposed as, monosomy chromosome 3 , followed by additional 8q (often as an isochromosome), which is subject to amplification (Sisley et al, 1997) , possibly accompanied at some later point by deletions of chromosome 1p and/or trisomy 21. In choroid melanomas the situation is less apparent, although the common involvement of chromosomes 6 and 11 alterations would suggest they may play a role. Since chromosome 6 rearrangements were detected in more 4 Cells 47,XX,-3,+add(8)(p11),del(11)(q23),+mar,inc Som 30 8 Cells 44,XY,-3,-6,i(8)(q10),+i(8)(q10),der(9)t(6;9)(p12;q21),-17 5 Cells 43,XY,-3,-6,i(8)(q10),+i(8)(q10),der(9)t(6;9)(p12;q21),-16,-17 Som 35
4 Cells 46,X,-Y,-3,i(6)(p10),+7,i(8)(q10),+i (8) 27 Cells 46,XY,der(6)t(6;6)(q27;p12),del(11)(q23),add(12)(q24),add(14)(q32), add(18)(q23),add(19)(q13),add (22))(q13) Som 52
11 Cells 46,XX,t(1;10)(p13;q24),-3,i(8)(q10),+i(8)(q10),del(11)(q23) 9 Cells 46,XX,t(1;10)(p13;q24),-3,+i(8)(q10),del(11)(q23) 6 Cells 45,XX,t(1;10)(p13;q24),-3,+i(8)(q10),del(11)(q23) Som 53 17 Cells 44,XY,-3,add(6)(q13-14),-9,der(17)t(9;17)(q10;q10) 5 Cells 43,XY,-3,add(6)(q13-14),-9,-13,der(17)t(9;17)(q10;q10) 4 Cells 44,XY,-3,add(6)(q13-14),-9,-13,der(17)t(9;17)(q10;q10)+mar Som 57
14 Cells 46,XX 3 Cells 45,XX,-3,i(8)(q10) Som 59 10 Cells 49,XY,+8,der(13)t(6;13)(p12;q34),+der (13) melanomas, it may be reasonable to expect that such changes occur prior to those of chromosome 11, of which breakpoints at, or around, 11q23 appear to be particularly implicated. In uveal melanoma there is a remarkable consistency for reported structural aberrations (Prescher et al, 1990 (Prescher et al, , 1995 Sisley et al, 1990 Sisley et al, , 1992 Dahlenfors et al, 1993; Horsman and White, 1993; Wiltshire et al, 1993; Singh et al, 1994) , which in some instances includes both the selection of translocation partners and the location of breakpoints (Figures 1 and 2) . In this study the frequent structural rearrangements of chromosome 1 are particularly interesting in this respect. These exchanges appear to be nonrandom yielding consistent genetic imbalances (deletions of 1p), perhaps important to the development, in particular the progression, of mainly ciliary body melanomas. Similar changes are also a common event in cutaneous melanomas, possibly associated with tumour progression, and several genes have been implicated (Dracopoli et al, 1989) . In posterior uveal melanoma there appears to be a surprising affinity for certain translocation partners of chromosome 1 (Figure 2 ) particularly amongst the D Group, with reported cases detailing repeated involvement of chromosomes 8, 13, and 15 in comparable translocations with the same, or similar, breakpoints implicated (Prescher et al, 1990; Sisley et al, 1990 Sisley et al, , 1992 Horsman and White, 1993; Tappin et al, 1996) . This reproducibility suggests an underlying mechanism in which regions containing highly repetitive DNA sequences are strategically implicated. An analogous situation is perhaps found in breast cancer, where a reproducible translocation affecting chromosomes 1 and 16 has been observed (Kokalj-Vokac et al, 1993) . The breakpoints were found to span the heterochromatic regions, with the significant event considered to be the ensuing imbalance (KokaljVokac et al, 1993) . In posterior uveal melanoma in addition to the net imbalance, the preferential affiliation for repetitive sequences, without a prerequisite for pairing with the same homologue, may suggest other motives, perhaps related to deficiencies in DNA repair (Surralles et al, 1997) . Whether this selection is essential or coincidental awaits disclosure.
Cytogenetic analysis of posterior uveal melanoma appears to provide valuable insights into the necessary genetic alterations related to its development and progression. This study would suggest that in addition to changes of chromosome 3 and 8, alterations of chromosomes 1 and 21 correlate with ciliary body melanomas, whereas in choroid melanomas abnormalities of chromosomes 6 and 11 are more frequent. It is also of interest that structural rearrangements of chromosome 1 appear to associate with tumour progression and in particular the consistency of breakpoints involved in these alterations may help to identify the underlying genes responsible for such behaviour. 10 cells 46,XY,del(1)(p?),add(6)(q21-25),add(9)(q34), der(10)(t(8;10)(q11;p13),der(18)t(6;18)(p21;q23) Som 125 6 cells 48,X,-X,del(1)(p36),+del(1)(p36),-3,i(8)(q10),+i(8)(q10)×2, +der(8)t(8;8)(p23;q23) 4 cells 48,X,-X,del(1)(p36),+del(1)(p36),-3,i(8)(q10),+i(8)(q10)×2, +der (8) 
